|
Contents
|
|
|
|
Glioblastoma |
|
|
|
Aoki T, Takahashi JA, Ueba T, Oya N, Hiraoka M, Matsui K,
Fukui T, Nakashima Y, Ishikawa M, Hashimoto
N.
Phase II study of nimustine, carboplatin,
vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme:
experience of the Kyoto Neuro-Oncology Group.
J Neurosurg.
2006 Sep;105(3):385-91.
.JPG)
Abstract
|
|
|
Motomura
K, Natsume A, Kishida Y, Higashi H, Kondo Y, Nakasu Y, Abe T, Namba H, Wakai
K, Wakabayashi T.
Benefits of interferon-β
and temozolomide combination therapy for newly
diagnosed primary glioblastoma with the unmethylated MGMT promoter: A
multicenter study.
Cancer. 2011 Apr 15;117(8):1721-30.
Abstract |
.gif) Related articles
|
|
|
Recurrent
Tumors |
|
|
|
M. D. Groves, V.
Puduvalli, M. R. Gilbert, C. A. Conrad, S.
Hsu, H. Colman, K. Hess, V. A.
Levin and W. K. A. Yung
A phase II study of temozolomide plus pegylated interferon alfa-2b for
recurrent anaplastic glioma and glioblastoma multiforme
2005
ASCO Annual Meeting. Orlando, FL. May 13-17. Abstract No. 1519
Journal of Clinical Oncology, Vol 23, No 16S (June 1 Supplement), 2005:
1519
Abstract
|
|
|
Utsuki
S, Oka H, Miyajima Y, Sato K, Shimizu S, Suzuki S, Fujii K.
Effectiveness of
interferon-beta therapy for recurrent glioblastoma: a case report.
Tumori. 2011 Jan-Feb;97(1):119-22.
Abstract |
.png)
Reprint |
Related articles
|
|
|
|
